A focus on international regulations on IVD

SMi Group’s 3rd In Vitro Diagnostics conference will be take place on the 14th & 15th of June in London, bringing together global leading experts within the medical industry as they focus on the latest international trends within the field.
Aimed at Managers/Heads and Directors of Regulatory Affairs, In Vitro Diagnostics, Clinical Affairs and Quality Assurance, In Vitro Diagnostics 2017 will provide regulatory updates and key industry feedback from leading manufacturers within this complex and ever-changing landscape.

Read more: IVD

Expert speaker panel continues to grow for Asthma & COPD 2017

SMi’s 13th annual show dedicated to discussing Asthma & COPD will be returning to London this March.

EURRUS and Imperial College London have recently been added to the expert speaker panel at this year’s event. They will present alongside respiratory specialists from MHRA, GSK, Boehringer Ingelheim, Glenmark Pharmaceuticals, Janssen, Teva UK, AstraZeneca, MedImmune and many more to reflect on the ongoing issues and latest developments of these two diseases.

Read more: Expert speaker panel continues to grow for Asthma & COPD 2017
GCC Pharma Regulatory Summit
Regulation Pharmacovigilance Market Access

10-11 April 2017 | THE HABTOOR GRAND RESORT, DUBAI

To request a press accreditation for the event, please, contact This email address is being protected from spambots. You need JavaScript enabled to view it.

 

PRA is launching the GCC Pharma Regulatory Summit that will take place on the 10-11th of April 2017.
The summit also includes:
9th of April: Master class on e-CTD
12-13th of April: Pharmacovigilance training

The summit will give a full picture of the specifics of regulating the pharma market in the GCC region: UAE, Kingdom of Saudi Arabia, Bahrain, Kuwait, Qatar and Oman.

Read more: GCC Pharma Regulatory Summit

PHARM Connect Congress 2017

22nd-23rd February 2017 Budapest, HUNGARY

The PHARM Connect Congress 2017 offers the perfect setting for pharmaceutical and biotechnological solution providers to present their products and services directly to key decision makers of target client population throughout Central Eastern Europe.

Read more: PHARM Connect Congress 2017

Controlled Release Delivery 2017: Strengthening innovation and overcoming the challenging regulatory landscape

SMi will once again return to London for the 14th annual Controlled Release Delivery show which will take place on the 3rd & 4th of April.

Controlled Release Delivery 2017 will provide practical and critical discussions on the latest innovation in controlled release drug delivery. Alongside this, the conference will strengthen understanding in the latest regulatory landscape.

Aimed at drug development experts and formulation specialists, the 2017 event will explore key topics such as innovations in drug delivery, nanoparticles/nanomedicine & QbD, CNS drug delivery and therapeutic application.

Read more: Controlled Release Delivery 2017: Strengthening innovation and overcoming the challenging...
Global medicine

Beyond Brexit and EU Falsified Medicine Directive

SMi Group Reports: (2016.11.16, London, UK): Over 90 senior leaders in parallel trade will meet in London in February 2017 to discuss upcoming trends and share best practices.


With Brexit and the new EU Falsified Medicine Directive, what does the future hold for parallel trade? SMi’s Parallel Trade conference will be returning to London next February 6th-7th, for its 11th year, to discuss short term and long term concerns of pharma manufacturers, regulators and parallel traders. They will engage in an interactive debate and discuss how to keep abreast of the current trends and how to overcome all challenges.

Read more: Pharma Parallel Trade